Amanda Feilding
VC Fund
Amanda Feilding is an investment firm.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Amanda Feilding invests in
Stages Amanda Feilding invests in
Countries Amanda Feilding invests in
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Homecoming
|
Homecoming is a provider of patient engagement tools for psychedelic therapy. | $4M / Seed / Apr 07, 2022 |
Co-Investors
Bridge Builders Collaborative
1 deal together
Evolve Ventures
1 deal together
JLS Fund
1 deal together
Lionheart Ventures
1 deal together
SV Angel
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Amanda Feilding invest in?
Amanda Feilding invests primarily in Medical and Health Care startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Amanda Feilding last invest?
The most recent investment recorded for Amanda Feilding closed in Apr 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
